Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Jazz Pharmaceuticals Insider Sold Shares Worth $19,207,098, According to a Recent SEC Filing

Jazz Pharmaceuticals Insider Sold Shares Worth $19,207,098, According to a Recent SEC Filing

MT newswireMT newswire2026/09/01 07:42
03:42 AM EDT, 09/01/2026 (MT Newswires) -- Robert Iannone, Executive Vice President, Global Head of Research and Development and Chief Medical Officer, on August 27, 2026, sold 76,921 shares in Jazz Pharmaceuticals (JAZZ) for $19,207,098. Following the Form 4 filing with the SEC, Iannone has control over a total of 65,686 ordinary shares of the company, with 65,686 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1232524/000173732926000016/xslF345X05/edgardoc.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!